This shift of CXCR3 isoform usage appeared to loosely parallel that of E-cadherin, the main and only consistent marker of the epithelial phenotype in carcinoma cells during progression, which is down-regulated to variable degrees during both primary and secondary EMT of cancer progression. Here, CXCR3 is linked to carcinoma.